- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Updates, 23-12-2025: Press Release
23-12-2025 | 05:34 pm
23-12-2025 | 05:34 pm
Biocon inked an out-licensing pact with Ajanta Pharma for Semaglutide. Biocon will supply the type-2 diabetes drug for marketing in 26 countries across Africa, Middle East, and Central Asia, expanding its GLP-1 portfolio's global reach and market access.
No comments yet. Be the first to comment!